TITLE

Trimethoprim-Sulfamethoxazole or Pentamidine for Pneumocystis carinii Pneumonia in the Acquired Immunodeficiency Syndrome

AUTHOR(S)
Wharton, J. Marcus; Coleman, Diana Lewis; Wofsy, Constance B.; Luce, John M.; Blumenfeld, Walter; Hadley, W. Keith; Ingram-Drake, Leslie; Volberding, Paul A.; Hopewell, Philip C.
PUB. DATE
July 1986
SOURCE
Annals of Internal Medicine;Jul86, Vol. 105 Issue 1, p37
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents a study that examined the efficacy of trimethoprim-sulfamethoxazole or pentamidine isethionate for the treatment of Pneumocystis carinii pneumonia in patients with AIDS. Medical history of the patients; Methodology; Results and discussion.
ACCESSION #
6998543

 

Related Articles

  • Trimethoprim--Sulfamethoxazole Compared with Pentamidine for Treatment of Pneumocystis carinii Pneumonia in the Acquired Immunodeficiency Syndrome. Sattler, Fred R.; Cowan, Robert; Nielsen, Donald M.; Ruskin, Joel // Annals of Internal Medicine;8/15/88, Vol. 109 Issue 4, p280 

    Ascertains the efficacy and toxicity of trimethoprim-sulfamethoxazole or pentamidine during the treatment period for Pneumocystis carinii pneumonia in patients with AIDS. Adverse drug effects; Dosage and treatment modifications; Determinants of toxicity; Effect of increased severity of illness.

  • Cotrimoxazole.  // Reactions Weekly;1/21/2017, Vol. 1635 Issue 1, p95 

    An abstract of the article "Successful treatment of severe Pneumocystis pneumonia in an immunosuppressed patient using caspofungin combined with clindamycin: A case report and literature review" by H. Li and others is presented.

  • Dapsone-Trimethoprim for Pneumonia in the Acquired Immunodeficiency Syndrome. Leoung, Clifford S.; Mills, John; Hopewell, Philip C.; Hughes, Walter; Wofsy, Constance // Annals of Internal Medicine;Jul86, Vol. 105 Issue 1, p45 

    Presents a study that examined the efficacy of dapsone plus trimethoprim for the treatment of patients with AIDS and a first episode of Pneumocystis carinii pneumonia. Methodology; Characteristics of patients with AIDS and Pneumocystis carinii pneumonia treated with dapsone-trimethoprim;...

  • Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study. Helweg-Larsen, Jannik; Benfield, Thomas; Atzori, Chiara; Miller, Robert F. // Journal of Antimicrobial Chemotherapy (JAC);Dec2009, Vol. 64 Issue 6, p1282 

    Objectives: First-line therapy for Pneumocystis jirovecii pneumonia (PCP) is trimethoprim/sulfamethoxazole. Few data exist to guide the choice of second-line therapy for patients failing or developing toxicity to first-line therapy.

  • DALLAS GAYS SET UP 'GUERRILLA' AIDS CLINIC. Vandervelden, Mark // Advocate;4/26/88, Issue 497, p14 

    Reports on the dispensation of aerosol pentamidine isethionate at the Dallas AIDS Resource Center, Texas. Pentamidine isethionate as experimental drug for the treatment of Pneumocystis carinii pneumonia; Refusal of Parkland Memorial Hospital in Dallas County to administer the drug; Dallas Gay...

  • Par Pharmaceutical Gains Rights To Phase III Drug From Immtech. Shrine, Jim // BioWorld Today;6/13/2007, Vol. 18 Issue 114, p1 

    The article reports that Par Pharmaceutical Cos. Inc. acquired exclusive rights in the U.S. to a Phase III drug from Immtech Pharmaceuticals Inc. for treating pneumocystis pneumonia in acquired immune deficiency syndrome (AIDS) patients. The goal of the Phase III study is to demonstrate...

  • Bacterial resistance to TMP-SMX up markedly, particularly among HIV-infected patients.  // Formulary;Feb2000, Vol. 35 Issue 2, p190 

    Discusses the report `Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era,' by J.N. Martin, D.A. Rose and W.K. Hadley, which appeared in a 1999 issue of `Journal of Infectious Diseases.'

  • Resistance to Trimethoprim-Sulfamethoxazole. Huovinen, Pentti // Clinical Infectious Diseases;6/1/2001, Vol. 32 Issue 11, p1608 

    Discusses the use of trimethoprim (TMP)-sulfamethoxazole as treatment and prophylaxis of patients with urinary tract infections. Mechanisms of bacterial resistance; Use of TMP and sulfonamides.

  • Low--Dose Trimethoprim--Sulfamethoxazole Prophylaxis for Toxoplasmic Encephalitis in Patients with AIDS. Carr, Andrew; Tindall, Brent; Brew, Bruce J.; Marriott, Deborah J.; Harkness, John L.; Penny, Ronald; Cooper, David A. // Annals of Internal Medicine;7/15/92, Vol. 117 Issue 2, p106 

    Focuses on a study which determined the efficacy of low-dose trimethoprim-sulfamethoxazole as primary prophylaxis against toxoplasmic encephalitis in patients with HIV infection. Information on toxoplasmic encephalitis; Methodology of the study; Results and discussion.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics